Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DICUMAROL Cause Hyperparathyroidism secondary? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hyperparathyroidism secondary have been filed in association with DICUMAROL. This represents 73.3% of all adverse event reports for DICUMAROL.

11
Reports of Hyperparathyroidism secondary with DICUMAROL
73.3%
of all DICUMAROL reports
0
Deaths
0
Hospitalizations

How Dangerous Is Hyperparathyroidism secondary From DICUMAROL?

Of the 11 reports.

Is Hyperparathyroidism secondary Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DICUMAROL. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does DICUMAROL Cause?

Chest pain (11) Cough (11) Osteoporosis (11) Pleuritic pain (11) Rib fracture (11) Upper respiratory tract infection (11)

What Other Drugs Cause Hyperparathyroidism secondary?

ESOMEPRAZOLE (1,357) OMEPRAZOLE (1,274) PANTOPRAZOLE (947) LANSOPRAZOLE (888) DEXLANSOPRAZOLE (382) RABEPRAZOLE (108) DENOSUMAB (60) FUROSEMIDE (49) OMEPRAZOLE\SODIUM BICARBONATE (48) ESOMEPRAZOLE\NAPROXEN (47)

Related Pages

DICUMAROL Full Profile All Hyperparathyroidism secondary Reports All Drugs Causing Hyperparathyroidism secondary DICUMAROL Demographics